 |
 |
| |
|
|
| |
The global life sciences sector has grown and changed significantly in recent years. We expect it to focus on incorporating digital technology, managing market fluctuations and addressing healthcare disparities in 2023 and beyond. By implementing effective strategies and capabilities, life sciences companies could continue to provide value to patients, healthcare providers and other stakeholders. Healthcare leaders must stay up to date on industry trends if they are to identify expansion opportunities and improve patient care.
Acuity’s life sciences and healthcare support provides the most recent developments in healthcare and life sciences that may have a significant impact on the sector. Enjoy the read.
Manish Chandna – Director and Global Head, Consulting and Corporates
|
|
| |
|
|
|
Fresh and unique: Hand-picked content carefully curated for you
|
|
| |
|
|
|
|
The evolving life sciences sector |
|
The immuno-oncology market
|
 |
|
 |
|
|
|
This blog focuses on recent trends in the life sciences sector such as intelligent automation and decentralised clinical trials.
|
|
In this blog, we take a closer look at the immuno-oncology market, its segments, leading immuno-oncology therapies, challenges and key strategies.
|
|
|
|
|
|
| |
|
|
|
|
Impact Story: An assessment of the GCC pharmaceutical market |
|
Impact Story: Patient segmentation and prioritisation
|
 |
|
 |
|
|
|
Learn how we overcame client challenges with our market assessment and analysed the participation of private hospitals and health policies while assessing possible market drivers..
|
|
Read how we identified niche patient pools, gained secondary-market research, assessed the severity level of co-morbidities and provided support to formulate actionable insights.
|
|
|
|
|
| |
|
|
|
|
|
Solution focus
|
|
| |
|
|
|
|
Life sciences solutions and pharmaceutical research |
|
Bespoke research support for cancer immunotherapies
|
 |
|
 |
|
|
|
We provide customised research solutions to life sciences and healthcare companies to help them understand the market and competitive landscape, improve productivity, conduct pipeline analysis, assess therapeutic areas and formulate effective strategies.
|
|
Explore how our healthcare experts can provide support on the latest trends and emerging immunotherapies, current limitations, opportunities, developments and growth areas in this space.
|
|
|
|
|
|
| | | |
| |
| | |
| | |
ABOUT ACUITY KNOWLEDGE PARTNERS
Acuity Knowledge Partners is a leading research, analytics, and business intelligence consultant to the financial services sector. The company’s network of analysts and industry experts, combined with advanced data and technology, supports over 520 financial institutions and consulting companies worldwide to operate more efficiently, and unlock their human capital, driving revenue higher and transforming operations. It specialises in investment banking, investment research, private equity and consulting, and commercial lending. Acuity is headquartered in London and operates from nine locations worldwide. In 2019, the company was established as a separate business from Moody’s Corporation through its acquisition by Equistone Partners.
For more information, please visit https://www.acuitykp.com/about-us/
|
|
| | | | | | US: +1 929 618 0217 | UK: +44 20 7550 4499 | India: +91 80 6113 3000
Sri Lanka: +94 11 235 6000 | Beijing: +86 10 8248 6812 | HK: +852 (972) 836-39 | contact@acuitykp.com | |
| | | |
| | | | | | ©2023 Acuity Knowledge Partners. All rights reserved. | |
| | | |
| |